Original Date: June 3-4, 2017

Small intestine bacterial overgrowth (SIBO) is a chronic bacterial colonization of the small intestine. These bacteria normally live in the gastrointestinal tract, however, in SIBO they have overgrown in a location not meant for so many bacteria. The bacteria interfere with our normal digestion and absorption of food and are associated with damage to the lining or membrane of the small intestine. These mechanisms in turn lead to myriad other disorders—gastrointestinal, systemic, and neurological.

The 4th Annual SIBO Symposium features the nation’s leading experts on the topic to present an evidence-based educational program on managing small intestine bacterial overgrowth. For more information, visit www.sibosymposium.com

Presentations include:

• SIBO Overview
• Risk Factors and Environmental Toxins
• Methane and Autoimmunity
• Low-Dose Naltrexone and Low-Dose Erythromycin
• Managing Treatment Failures in SIBO, IBS and IBD
• Overview of Nutritional Therapies
• Elemental Diet Protocol
• Expert Panel
• NUNM Research Update
• Methylation, Genomics, and SIBO

3.5 Pharmacology and 8.75 General (Total 12.25 CEUs) approved by OBNM

10.25 Category B credits approved by the California Board of Chiropractic Examiners